Related Experiment Videos
Reduction of left ventricular hypertrophy in hypertensive patients after treatment with celiprolol
J M Herrmann1, F Bischof, F Von Heymann
1Department of Psychosomatic Medicine, University of Ulm, Federal Republic of Germany.
Insights
Long-term treatment with celiprolol, a cardioselective beta blocker, effectively lowered blood pressure in patients with essential hypertension. The study also indicated a reduction in left ventricular hypertrophy, suggesting celiprolol
Area of Science:
- Cardiology
- Pharmacology
Background:
- Essential hypertension is a prevalent cardiovascular condition.
- Left ventricular hypertrophy (LVH) is a common complication of uncontrolled hypertension.
Purpose of the Study:
- To evaluate the efficacy and safety of long-term celiprolol treatment in essential hypertension.
- To assess the impact of celiprolol on left ventricular hypertrophy.
Main Methods:
- A study involving 14 patients with World Health Organization stages I to II essential hypertension.
- Long-term administration of celiprolol, a cardioselective beta blocker.
- Measurement of blood pressure, heart rate, and end-systolic septum thickness in a subset of patients.
Main Results:
- Significant reduction in blood pressure observed during long-term celiprolol treatment.
- Heart rates remained within normal limits throughout the study.
- No significant adverse effects were reported.
- Evidence of reduced left ventricular hypertrophy in 4 patients.
Conclusions:
- Celiprolol is a safe and effective option for the long-term management of essential hypertension.
- Celiprolol treatment may help reverse or reduce hypertension-induced left ventricular hypertrophy.
Abstract:
Long-term treatment with celiprolol, a new cardioselective beta blocker, significantly reduced blood pressure in 14 patients with essential hypertension (World Health Organization stages I to II). Heart rates remained within the normal range throughout treatment and no significant side effects were observed. In 4 patients, end-systolic septum thickness was measured, and evidence was obtained that the extent of left ventricular hypertrophy was reduced. These findings indicate that celiprolol can be used for the successful long-term treatment of essential hypertension, and that such treatment reduces left ventricular hypertrophy induced by high blood pressure.